Skip to main content
Top
Published in: Multidisciplinary Respiratory Medicine 1/2015

Open Access 01-12-2016 | Letter to the Editor

Cost comparison of asthma treatments in 12-week study: caution about matching and short observational follow-up

Authors: David B. Price, Job F. M. van Boven, Lisa M. Law, Alessandra Cifra, R. Brett McQueen

Published in: Multidisciplinary Respiratory Medicine | Issue 1/2015

Login to get access

Abstract

In the absence of randomisation, observational studies must take extra care to create treatment groups that are comparable in terms of key characteristics. Various matching methods exist which can create sound comparisons, minimising confounding where possible. A recent observational study by Dal Negro et al. carried out a cost analysis comparing two asthma medications. They report strong conclusions which favour one treatment over the other, however they include little discussion on the limitations of their study. The purpose of this letter is to comment on the weaknesses of the study design, including the level of matching used, and to urge readers to consider these issues alongside the interpretation of results.
Literature
1.
go back to reference Price D, Wilson AM, Chisholm A, Rigazio A, Burden A, Thomas M, et al. Predicting frequent asthma exacerbations using blood eosinophil count and other patient data routinely available in clinical practice. J Asthma Allergy. 2016;9:1–12.CrossRefPubMedPubMedCentral Price D, Wilson AM, Chisholm A, Rigazio A, Burden A, Thomas M, et al. Predicting frequent asthma exacerbations using blood eosinophil count and other patient data routinely available in clinical practice. J Asthma Allergy. 2016;9:1–12.CrossRefPubMedPubMedCentral
2.
go back to reference Gray AM CP, Wolstenholme JL, Wordsworth S. Applied Methods of Cost-Effectiveness Analysis in Health Care. New York: Oxford University Press; 2011. Gray AM CP, Wolstenholme JL, Wordsworth S. Applied Methods of Cost-Effectiveness Analysis in Health Care. New York: Oxford University Press; 2011.
4.
go back to reference Lotvall J, Bleecker ER, Busse WW, O’Byrne PM, Woodcock A, Kerwin EM, et al. Efficacy and safety of fluticasone furoate 100 ug once-daily in patients with persistent asthma: a 24-week placebo and active-controlled randomised trial. Respir Med. 2014;108(1):41–9.CrossRefPubMed Lotvall J, Bleecker ER, Busse WW, O’Byrne PM, Woodcock A, Kerwin EM, et al. Efficacy and safety of fluticasone furoate 100 ug once-daily in patients with persistent asthma: a 24-week placebo and active-controlled randomised trial. Respir Med. 2014;108(1):41–9.CrossRefPubMed
5.
go back to reference Woodcock A, Bleecker ER, Lotvall J, O’Byrne PM, Bateman ED, Medley H, et al. Efficacy and safety of fluticasone furoate/vilanterol compared with fluticasone propionate/salmeterol combination in adult and adolescent patients with persistent asthma: a randomized trial. Chest. 2013;144(4):1222–9.CrossRefPubMedPubMedCentral Woodcock A, Bleecker ER, Lotvall J, O’Byrne PM, Bateman ED, Medley H, et al. Efficacy and safety of fluticasone furoate/vilanterol compared with fluticasone propionate/salmeterol combination in adult and adolescent patients with persistent asthma: a randomized trial. Chest. 2013;144(4):1222–9.CrossRefPubMedPubMedCentral
6.
go back to reference Chong J, Haran C, Chauhan BF, Asher I. Intermittent inhaled corticosteroid therapy versus placebo for persistent asthma in children and adults. Cochrane Database Syst Rev. 2015;7:CD011032.PubMed Chong J, Haran C, Chauhan BF, Asher I. Intermittent inhaled corticosteroid therapy versus placebo for persistent asthma in children and adults. Cochrane Database Syst Rev. 2015;7:CD011032.PubMed
7.
go back to reference Edwards SJ, von Maltzahn R, Naya IP, Harrison T. Budesonide/formoterol for maintenance and reliever therapy of asthma: a meta analysis of randomised controlled trials. Int J Clin Pract. 2010;64(5):619–27.CrossRefPubMed Edwards SJ, von Maltzahn R, Naya IP, Harrison T. Budesonide/formoterol for maintenance and reliever therapy of asthma: a meta analysis of randomised controlled trials. Int J Clin Pract. 2010;64(5):619–27.CrossRefPubMed
8.
go back to reference Akinbami LJ, Sullivan SD, Campbell JD, Grundmeier RW, Hartert TV, Lee TA, et al. Asthma outcomes: healthcare utilization and costs. J Allergy Clin Immunol. 2012;129(3 Suppl):S49–64.CrossRefPubMedPubMedCentral Akinbami LJ, Sullivan SD, Campbell JD, Grundmeier RW, Hartert TV, Lee TA, et al. Asthma outcomes: healthcare utilization and costs. J Allergy Clin Immunol. 2012;129(3 Suppl):S49–64.CrossRefPubMedPubMedCentral
Metadata
Title
Cost comparison of asthma treatments in 12-week study: caution about matching and short observational follow-up
Authors
David B. Price
Job F. M. van Boven
Lisa M. Law
Alessandra Cifra
R. Brett McQueen
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Multidisciplinary Respiratory Medicine / Issue 1/2015
Electronic ISSN: 2049-6958
DOI
https://doi.org/10.1186/s40248-016-0076-x

Other articles of this Issue 1/2015

Multidisciplinary Respiratory Medicine 1/2015 Go to the issue